KRAS and neoplasm: Overall, although activation of autophagy is frequently observed in PDAC and other tumour types with oncogenic activation of the ERK/MAPK pathway,41 the dependency of KRAS-mutant tumours on autophagy seems model- and tumour-type dependent.